Utilizing cutting-edge DNA-Based sensors to provide real-time monitoring of hormone levels in the interstitial fluid, a minimally invasive method unlocking access to hormonal data.
Total raised: $6.92M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.02.2025 | - | $6.92M | Entreprene... |
Mentions in press and media 3
| Date | Title | Description |
| 19.02.2025 | Level Zero Health bags £5.5, the largest Pre-Seed round raised by a European female-founded company | It's not every day that you hear about the application of a kind of life-changing tech and wonder why it hasn't always existed. Sensor-powered continuous monitoring has transformed the lives of millions of diabetics. But why isn't it used i... |
| 18.02.2025 | Level Zero Health lands €6.6 million for “world’s first” continuous hormone monitoring device | London-based HealthTech startup Level Zero Health today announced a €6.6 million pre-Seed funding round to enable remote and continuous hormone monitoring, using unique DNA-based sensors. The funding round was led by European VC redalpine. ... |
| - | Level Zero Health | “Utilizing cutting-edge DNA-Based sensors to provide real-time monitoring of hormone levels in the interstitial fluid, a minimally invasive method unlocking access to hormonal data.” |